Cargando…

A proposal to analyze the progression of non-dialytic chronic kidney disease by surrogate endpoints: introducing parametric survival models

INTRODUCTION: Chronic kidney disease (CDK) progression studies increasingly use surrogate endpoints based on the estimated glomerular filtration rate. The clinical characteristics of these endpoints bring new challenges in comparing groups of patients, as traditional Cox models may lead to biased es...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erohildes Ferreira, Renato, Sanders-Pinheiro, Helady, Basile Colugnati, Fernando Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232791/ https://www.ncbi.nlm.nih.gov/pubmed/37275387 http://dx.doi.org/10.3389/fmed.2023.1029165

Ejemplares similares

Similar quality in chronic kidney disease multidisciplinary follow-up between kidney
por: Carminatti, Moisés, et al.
Publicado: (2020)

Nonadherence to immunosuppressives and treatment in kidney transplant: ADHERE BRAZIL Study
por: Marsicano-Souza, Elisa Oliveira, et al.
Publicado: (2021)

Prevalence and correlates of non-adherence to immunosuppressants and to health behaviours in patients after kidney transplantation in Brazil – the ADHERE BRAZIL multicentre study: a cross-sectional study protocol
por: Sanders-Pinheiro, Helady, et al.
Publicado: (2018)

Multilevel Correlates of Non-Adherence in Kidney Transplant Patients Benefitting from Full Cost Coverage for Immunosuppressives: A Cross-Sectional Study
por: Marsicano, Elisa Oliveira, et al.
Publicado: (2015)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Dermatosis in dialytic chronic kidney failure
por: Favero, Marina Luiza Dalla Costa, et al.
Publicado: (2022)

The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005)

Surrogate Endpoints in Medicine
por: Srivastava, Sudhir, et al.
Publicado: (2002)

Erratum: Dermatosis in dialytic chronic kidney failure
Publicado: (2022)

Non-dialytic management of acute kidney injury in newborns
por: Pandey, Vishal, et al.
Publicado: (2016)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

Management strategies for implementing a multicenter cross-sectional study: lessons from the ADHERE Brazil study
por: Marsicano-Souza, Elisa Oliveira, et al.
Publicado: (2022)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants
por: Marsicano, Elisa de Oliveira, et al.
Publicado: (2013)

Overview of Biomarkers and Surrogate Endpoints in Drug Development
por: Wagner, John A.
Publicado: (2002)

Is critical care ready for an economic surrogate endpoint?
por: Wilcox, M Elizabeth, et al.
Publicado: (2015)

Surrogate endpoints in early prostate cancer research
por: Williams, Scott
Publicado: (2018)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease
por: Kim, Sun Moon, et al.
Publicado: (2016)

Statistical evaluation of surrogate endpoints: a systematic review
por: Ensor, Hannah, et al.
Publicado: (2013)

Bivariate network meta‐analysis for surrogate endpoint evaluation
por: Bujkiewicz, Sylwia, et al.
Publicado: (2019)

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma
por: Medeiros, Felipe A.
Publicado: (2017)

Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022)

Can Nephrologists Use Ultrasound to Evaluate the Inferior Vena Cava? A Cross-Sectional Study of the Agreement between a Nephrologist and a Cardiologist
por: Muniz Pazeli, José, et al.
Publicado: (2014)

2091: Evaluating the validity and utility of surrogate endpoints in clinical trials of chronic kidney disease (CKD)
por: Ying, Jian, et al.
Publicado: (2018)

Impact of a clinical pharmacist on a cardiovascular surrogate endpoint: a pilot study
por: Ripley, Toni L., et al.
Publicado: (2012)

Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities
por: Fiaccadori, Enrico, et al.
Publicado: (2010)

Retinal Neurovascular Impairment in Non-diabetic and Non-dialytic Chronic Kidney Disease Patients
por: Zeng, Xiaomin, et al.
Publicado: (2021)

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria
por: Jeeyapant, Atthanee, et al.
Publicado: (2017)

Surrogate endpoints and competing risk of death in cardiac arrest research
por: McCredie, Victoria A., et al.
Publicado: (2016)

Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015)

Surrogate endpoints in advanced sarcoma trials: a meta-analysis
por: Savina, Marion, et al.
Publicado: (2018)

Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
por: Barratt, Jonathan, et al.
Publicado: (2019)

Survival and Risk Factors Among Dialytic Acute Kidney Injury Patients After Cardiovascular Surgery
por: Silva, Andrea B. V., et al.
Publicado: (2018)

Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle
por: de Albuquerque Suassuna, Paulo G., et al.
Publicado: (2018)

Planning and analyzing clinical trials with composite endpoints
por: Rauch, Geraldine, et al.
Publicado: (2017)

Biomarkers and Surrogate Endpoints: How and When might They Impact Drug Development?
por: Lathia, Chetan D.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_vrr33beqv8mie71ik02a3jlkaq